CoChat

Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study

Open access
Nazir, Nigha, Nazir, Deeba, Mehmood, Rezwana, Wani, Zaid Ahmad, Raj, Rajnish · 2026 · Industrial Psychiatry Journal

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index; 10 of the 12 sources its claims cite were checked for support.

Abstract

Background: Around 40-60% of major depressive disorder (MDD) patients treated with either SSRIs or SNRIs have experienced emotional blunting. It is cited as a prevailing cause for discontinuation of antidepressant medications in patients with MDD. Aim: To determine the prevalence of emotional blunting with antidepressants in patients of MDD visiting psychiatric OPD in Kashmir. Materials and Methods: This was cross-sectional study conducted over a period of 18 months. A total of 369 patients were diagnosed as MDD as per DSM-5. A Hamilton Depression Rating Scale score of ≤7 and those on a single class of antidepressant for at least 2 months were taken up for the study. They were screened for emotional blunting, and those who responded in affirmative as mildly, moderately, or severely were further evaluated by asking them to finish the Oxford Depression Questionnaire. Results: The prevalence of emotional blunting in our study was reported to be 46.07%. The mean age of the participants was 40.9 ± 10.6 years with the majority being females (71%), married (69.38%), and from nuclear families (75.88%). Emotional blunting was most commonly associated with duloxetine (73.68%) and least with bupropion (31.82%). Nearly 40% of the patients had considered stopping their antidepressant due to emotional numbing. Conclusion: Recognizing and addressing emotional blunting is crucial in optimizing therapeutic outcomes and ensuring patient-centered care in depressive management. Given a significant number of depressive patients taking antidepressants may experience emotional blunting and subsequent discontinuation of the same. Routine assessment and timely management are essential for optimized clinical outcomes in patients with depression.

Overview

CoChat Summary

TL;DR

In this hospital-based cross-sectional study of 369 MDD patients in remission on antidepressant monotherapy in Kashmir, 46.07% experienced emotional blunting. Duloxetine was most commonly associated with emotional blunting (73.68%) and bupropion least (31.82%), with nearly 40% considering stopping their antidepressant due to emotional numbing.

Key findings

  • Of 369 patients, 170 (46.07%) experienced emotional blunting and 199 (53.93%) did not.
  • Mean age was 40.9 ± 10.6 years; the majority were female (71%), married (69.38%), and from nuclear families (75.88%).
  • Emotional blunting was most commonly associated with duloxetine (73.68%) and least with bupropion (31.82%); nearly 40% of patients had considered stopping their antidepressant due to emotional numbing.
  • Patients with emotional blunting had higher HDRS scores than those without; the study found a significant difference in ODQ scores and that emotional blunting was directly correlated with antidepressant dose, duration of illness, and total time on antidepressant monotherapy.

Methods

  • Hospital-based, noninterventional, cross-sectional study conducted at a tertiary care hospital over 18 months (November 2022 to April 2024).
  • Included 369 patients diagnosed with MDD per DSM-5, in remission (HDRS ≤7), aged 18 years and above, on a single class of antidepressant for at least 2 months, who provided written informed consent; excluded comorbid psychiatric disorders and other psychotropic medications.
  • Emotional blunting was screened with a validated question; those responding affirmatively as mild, moderate, or severe completed the Oxford Depression Questionnaire. Data were collected via structured clinical interview and treatment records, analyzed using SPSS version 23.0 with descriptive statistics, chi-square tests, and P < 0.05 considered significant.

Limitations

  • The paper states: no control group; sample size not calculated; cross-sectional design restricts causality; uncontrolled, nonblinded, time-limited, small sample size; possible selection and recall biases; and findings from a tertiary psychiatric facility may not generalize to community or primary care settings.
  • No additional limitations are evident beyond those stated in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4103/ipj.ipj_201_25

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 2 Not valid · 3 Not checked · 23 Own results and interpretations

17 more claims · 3 with their cited sources checked

Create a free account to see all 36 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 10
  • It may state two separate claims as one. 5

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Research works printed but not linked: 2

  1. Dar, 2016, Socio-demographic and clinical profile of patients suffering from severe depressive disorders in Kashmir valley, Int J Contemp Med Res, 3, 3389
  2. Ahmed, 2023, A cross sectional study to assess the role of socio-economic factors in causing depression among the rural population, J Community Health Manage, 6, 113

Cited by

See all 2

Metadata

Authors
Nazir, N., Nazir, D., Mehmood, R., Wani, Z. A., & Raj, R.
Affiliations
Government Medical College (IN)
Corresponding author
Raj, Rajnish
Venue
Industrial Psychiatry Journal
Published
2026-01
Volume
35
Issue
1
Pages
54-59
ISSN
  • 0972-6748 (ISSN-L)
  • 0976-2795
OpenAlex
W7124862549
Cited by
2
References
22
Citations by year
2026: 2
FWCI
5.46
Type
journal article
Language
en
Open access
Locations
  • Industrial Psychiatry Journal (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
emotional blunting, major depressive disorder, antidepressants, duloxetine, bupropion, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, antidepressant discontinuation, prevalence, Kashmir

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.